TickerFacts.

Integra Lifesciences Holdings Corp (IART): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$803.62M
Year ended 2025-12-31
$783.08M
Trailing 12 months to 2026-06-30
+11.0%
3-year compound annual growth
+9.1%
5-year compound annual growth
+9.4%
10-year compound annual growth
2008-12-31: $252.83M2009-12-31: $244.92M2010-12-31: $268.19M2011-12-31: $299.15M2012-12-31: $314.43M2013-12-31: $279.55M2014-12-31: $302.95M2015-12-31: $326.54M2016-12-31: $349.09M2017-12-31: $435.51M2018-12-31: $571.50M2019-12-31: $564.68M2020-12-31: $520.83M2021-12-31: $597.81M2022-12-31: $587.36M2023-12-31: $656.84M2024-12-31: $728.47M2025-12-31: $803.62M$803.62M
2008-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$803.62M+10.3%2026-02-26, From 2025-01-01
2024-12-31$728.47M+10.9%2026-02-26, From 2024-01-01
2023-12-31$656.84M+11.8%2026-02-26, From 2023-01-01
2022-12-31$587.36M-1.7%2025-02-25, From 2022-01-01
2021-12-31$597.81M+14.8%2024-02-28, From 2021-01-01
2020-12-31$520.83M-7.8%2023-02-22, From 2020-01-01
2019-12-31$564.68M-1.2%2022-02-24, From 2019-01-01
2018-12-31$571.50M+31.2%2021-02-23, From 2018-01-01
2017-12-31$435.51M+24.8%2020-02-21, From 2017-01-01
2016-12-31$349.09M+6.9%2019-02-26, From 2016-01-01
2015-12-31$326.54M+7.8%2018-03-01, From 2015-01-01
2014-12-31$302.95M+8.4%2017-02-23, From 2014-01-01
2013-12-31$279.55Mn/c2016-02-26, From 2013-01-01
2012-12-31$314.43M+5.1%2015-02-27, From 2012-01-01
2011-12-31$299.15M+11.5%2014-02-27, From 2011-01-01
2010-12-31$268.19M+9.5%2013-02-26, From 2010-01-01
2009-12-31$244.92M-3.1%2012-02-27, From 2009-01-01
2008-12-31$252.83Mn/a2011-02-24, From 2008-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Integra Lifesciences Holdings Corp (IART)2025-12-31$803.62M+10.3%
Merit Medical Systems Inc (MMSI)2025-12-31$777.64M+9.0%
Penumbra Inc (PEN)2025-12-31$461.23M+4.9%
Teleflex Inc (TFX)2025-12-31$871.96M+31.7%
Haemonetics Corp (HAE)2026-03-28$546.44M-10.7%
ICU Medical Inc (ICUI)2025-12-31$1.41B-9.5%
Embecta Corp. (EMBC)2025-09-30$403.60M+4.0%
Tandem Diabetes Care Inc (TNDM)2025-12-31$468.72M+4.0%
Insulet Corp (PODD)2025-12-31$768.20M+22.7%

Compare IART, MMSI, PEN, TFX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗